May 27, 2026 07:30AM
May 27, 2026 07:30AM
May 7, 2026 04:01PM
Mar 30, 2026 09:50AM
Feb 15, 2025 10:00PM
Dec 18, 2024 09:08AM
Nov 25, 2024 08:24AM BMO Capital Reiterates Market Perform Rating on BridgeBio Pharma (BBIO)
Nov 25, 2024 08:12AM
Nov 18, 2024 11:15AM
Nov 12, 2024 07:30AM
Sep 30, 2024 08:25AM
Sep 27, 2024 06:00PM
Sep 11, 2024 07:40AM
Aug 30, 2024 10:50AM BridgeBio Pharma (BBIO) Shares Data on Serum TTR Increase When Switching Participants from Placebo and Tafamidis to Acoramidis in ATTRibute-CM and its Open-Label Extension
Aug 30, 2024 10:50AM
Aug 2, 2024 12:19PM
Aug 1, 2024 07:30AM
Jun 24, 2024 11:36AM
May 30, 2024 05:39AM
May 29, 2024 04:01PM
May 13, 2024 07:30AM BridgeBio Pharma Inc. (BBIO) Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy
May 13, 2024 07:30AM
May 2, 2024 07:30AM
Apr 7, 2024 01:15PM
Mar 4, 2024 02:30AM
Feb 23, 2024 12:35PM
Feb 22, 2024 07:30AM
Feb 5, 2024 07:32AM BridgeBio Pharma (BBIO) Announces FDA Acceptance of New Drug Application for Acoramidis
Feb 5, 2024 07:30AM
Jan 31, 2024 03:46AM
Jan 6, 2020 07:31AM
Jan 6, 2020 07:30AM
Jan 6, 2020 07:30AM

15,416 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All